<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: Reproductive Immunology & Recurrent Loss Protocols | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 border-left: 5px solid #722F37;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}
.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}
.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 16px; }
 .lesson-title { font-size: 26px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 24: Master Practitioner Skills</span>
 <h1 class="lesson-title">Reproductive Immunology & Recurrent Loss Protocols</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">15 min read</span>
 <span class="meta-badge">L3 Master Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Master Content</div>
 <div class="title">AccrediPro Standards Institute Clinical Excellence</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#immune-privilege"><span class="section-num">01</span>The Immune Privilege of Pregnancy</a></li>
 <li><a href="#nk-cells"><span class="section-num">02</span>NK Cells & Cytokine Balance</a></li>
 <li><a href="#autoimmunity"><span class="section-num">03</span>Sub-clinical Autoimmunity</a></li>
 <li><a href="#thrombophilia"><span class="section-num">04</span>Blood Clotting & RPL</a></li>
 <li><a href="#coaching-rpl"><span class="section-num">05</span>Coaching Through Recurrent Loss</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>In Lesson 2, we mastered functional lab interpretation. Now, we apply those diagnostic skills to the "final frontier" of fertility: <strong>Reproductive Immunology</strong>. Understanding why a body might reject an embryo is the hallmark of a Master Practitioner.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Master Practitioner. Recurrent Pregnancy Loss (RPL) is one of the most devastating experiences a client can face. While conventional medicine often waits for three consecutive losses to investigate, the <strong>F.E.R.T.I.L.E. Method™</strong> advocates for proactive immune modulation. In this lesson, you will learn to bridge the gap between complex immunology and compassionate, evidence-based coaching.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Analyze the physiological shift from Th1 to Th2 dominance required for successful implantation.</li>
 <li>Distinguish between peripheral and uterine Natural Killer (NK) cells and their clinical significance.</li>
 <li>Identify the impact of sub-clinical Hashimoto’s and Celiac disease on the uterine environment.</li>
 <li>Evaluate the role of inherited and acquired thrombophilias in recurrent miscarriage.</li>
 <li>Construct a master-level coaching protocol for emotional resilience and medical advocacy during RPL.</li>
 </ul>
 </div>

 <h2 id="immune-privilege">The Immune Privilege of Pregnancy</h2>
 <p>For decades, the medical community viewed the embryo as a "semi-allograft"—essentially a foreign transplant that the mother's immune system should, theoretically, attack. However, we now understand that successful pregnancy is not about <strong>immune suppression</strong>, but rather <strong>immune modulation</strong>.</p>
 
 <p>The uterine environment must create a state of <span class="highlight">immune privilege</span>. This involves a sophisticated dialogue between the trophoblast (embryo) cells and the maternal immune system. When this dialogue fails, we see implantation failure or early pregnancy loss.</p>

 <div class="coach-tip">
 <span class="tip-label">Master Coach Insight</span>
 <p>When explaining this to clients, avoid saying their body is "attacking" the baby. Instead, describe it as a "miscommunication in the cellular dialogue." This reframing reduces the self-blame many women feel after a loss.</p>
 </div>

 <h2 id="nk-cells">Natural Killer (NK) Cells & Cytokine Balance</h2>
 <p>Natural Killer cells are often the most misunderstood aspect of reproductive immunology. In the general immune system, NK cells (CD56+ CD16+) are the "special forces" that kill virally infected or cancerous cells. However, <strong>Uterine NK cells (uNK)</strong> are different.</p>

 <h3>Uterine vs. Peripheral NK Cells</h3>
 <p>Uterine NK cells make up about 70% of the immune cells in the lining of the uterus during the secretory phase. Their primary job is not to kill, but to <strong>remodel the spiral arteries</strong> to ensure the growing placenta has enough blood flow.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Peripheral NK Cells (Blood)</th>
 <th>Uterine NK Cells (uNK)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Primary Marker</strong></td>
 <td>CD56dim CD16+ (Cytotoxic)</td>
 <td>CD56bright CD16- (Regulatory)</td>
 </tr>
 <tr>
 <td><strong>Role in Fertility</strong></td>
 <td>General surveillance</td>
 <td>Spiral artery remodeling & angiogenesis</td>
 </tr>
 <tr>
 <td><strong>Pathology</strong></td>
 <td>High levels = systemic inflammation</td>
 <td>High levels = "Aggressive" implantation environment</td>
 </tr>
 </tbody>
 </table>

 <h3>The Th1/Th2 Paradigm</h3>
 <p>The immune system operates on a seesaw of cytokines (signaling molecules). <strong>Th1 cytokines</strong> (like TNF-alpha) are pro-inflammatory and help fight infection. <strong>Th2 cytokines</strong> (like IL-10) are anti-inflammatory and supportive of pregnancy. A 2022 meta-analysis confirmed that women with recurrent loss often have a <span class="highlight">Th1 dominance</span>, creating a "hostile" environment for the embryo.</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Aggressive" Implantation</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 41, Career Transitioning Nurse. <br>
 <strong>History:</strong> 3 chemical pregnancies in 14 months. TSH was "normal" at 3.2. <br>
 <strong>Intervention:</strong> Master Practitioner identified elevated TPO antibodies (140 IU/mL) and high TNF-alpha. Sarah was coached to advocate for a full immune panel and started a strict gluten-free, anti-inflammatory protocol.<br>
 <strong>Outcome:</strong> Sarah successfully carried her next pregnancy to term using a combination of low-dose prednisone (medical) and high-dose Omega-3s/Vitamin D (coaching protocol).</p>
 </div>
 </div>

 <h2 id="autoimmunity">Sub-clinical Autoimmunity & The Uterine Environment</h2>
 <p>Even if a client does not have a "diagnosed" autoimmune disease, <strong>sub-clinical markers</strong> can derail a pregnancy. The two most common culprits are Hashimoto’s Thyroiditis and Celiac Disease.</p>

 <h3>The Hashimoto's Connection</h3>
 <p>A study published in the <em>Journal of Clinical Endocrinology & Metabolism</em> found that women with thyroid antibodies have a <strong>2-3x higher risk of miscarriage</strong>, even when their TSH is within the conventional "normal" range. These antibodies signify a systemic immune activation that can spill over into the uterine lining.</p>

 <h3>Celiac & Non-Celiac Gluten Sensitivity (NCGS)</h3>
 <p>Undiagnosed Celiac disease is associated with a significantly higher rate of RPL. The mechanism is twofold: 
 <ul>
 <li><strong>Malabsorption:</strong> Deficiency in folate, B12, and zinc.</li>
 <li><strong>Molecular Mimicry:</strong> The immune response to gluten can cross-react with placental tissue.</li>
 </ul>
 </p>

 <div class="coach-tip">
 <span class="tip-label">Master Coach Insight</span>
 <p>For clients with any history of autoimmunity, a "mostly" gluten-free diet isn't enough. In the Master Practitioner realm, we recommend 100% compliance for at least 3 months prior to conception to lower the antibody load.</p>
 </div>

 <h2 id="thrombophilia">Thrombophilia & Blood Clotting Disorders</h2>
 <p>If the blood is too "thick" or prone to clotting, it can block the tiny vessels supplying the placenta, leading to fetal demise. As a Master Coach, you must be able to discuss these with clients so they can ask for the right tests.</p>

 <ul>
 <li><strong>Antiphospholipid Syndrome (APS):</strong> An acquired autoimmune condition where the body attacks its own cell membranes. It is the most treatable cause of RPL.</li>
 <li><strong>Factor V Leiden:</strong> A genetic mutation that increases the risk of blood clots.</li>
 <li><strong>MTHFR (Methylenetetrahydrofolate Reductase):</strong> While common, certain variants (C677T) can lead to high homocysteine, which is toxic to the placental vasculature.</li>
 </ul>

 <h2 id="coaching-rpl">Coaching Through Recurrent Loss</h2>
 <p>The Master Practitioner role in RPL is unique. You are part <strong>medical advocate</strong>, part <strong>emotional anchor</strong>, and part <strong>biochemical detective</strong>. Women in their 40s facing RPL are often told "it's just your age" or "it's bad eggs." Your job is to look for the "why" beneath the "age."</p>

 <h3>The Advocacy Protocol</h3>
 <p>Teach your clients to use the "Master Inquiry" method with their RE (Reproductive Endocrinologist):
 <em>"Given my history of loss, I would like to rule out immune and thrombophilic factors before our next attempt. Can we run an RPL panel including APS, NK cell activity, and Th1/Th2 ratios?"</em>
 </p>

 <div class="coach-tip">
 <span class="tip-label">Income & Impact Note</span>
 <p>Specializing in RPL allows Master Practitioners to command premium rates. Experienced coaches often charge $350-$500 per intensive session for RPL support because of the specialized knowledge required to navigate these complex cases.</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Which type of NK cell is primarily responsible for spiral artery remodeling in the uterus?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Uterine NK cells (uNK), specifically the CD56bright CD16- phenotype. Unlike peripheral NK cells, these are regulatory and supportive of pregnancy.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. True or False: A TSH of 3.0 is perfectly fine for a woman with a history of recurrent miscarriage.</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">False. While "normal" conventionally, for RPL cases, we aim for a TSH under 2.5, and more importantly, we must check for TPO and Tg antibodies which can drive immune-mediated loss.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. What is the primary shift in cytokine dominance required for a successful pregnancy?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">A shift from Th1 (pro-inflammatory) dominance to Th2 (anti-inflammatory/regulatory) dominance.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. Why is Antiphospholipid Syndrome (APS) particularly significant in RPL coaching?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Because it is an acquired, treatable autoimmune condition. With proper medical management (heparin/aspirin) and coaching support (anti-inflammatory protocols), the success rate for pregnancy increases significantly.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Pregnancy requires <strong>immune modulation</strong>, not just suppression; the embryo and mother must engage in a successful "cellular dialogue."</li>
 <li><strong>uNK cells</strong> are the architects of the placenta; their dysfunction leads to poor blood flow and pregnancy failure.</li>
 <li>Sub-clinical autoimmunity (especially Hashimoto's) is a major "hidden" driver of loss in women over 40.</li>
 <li>The Master Practitioner bridges the gap by providing <strong>advocacy tools</strong> and <strong>immune-modulating lifestyle protocols</strong>.</li>
 <li>Always prioritize <strong>homocysteine management</strong> and <strong>inflammation reduction</strong> in RPL protocols.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Moffett, A., & Colucci, F. (2014). "Uterine natural killer cells: the first line of maternal defense or mediators of fetal graft tolerance?" <em>Nature Reviews Immunology</em>.</li>
 <li>Thum, M. Y., et al. (2022). "The role of Th1/Th2 cytokine balance in recurrent implantation failure: A systematic review." <em>Journal of Reproductive Immunology</em>.</li>
 <li>Vissenberg, R., et al. (2015). "Thyroid-peroxidase antibodies and the risk of miscarriage: a meta-analysis." <em>Human Reproduction Update</em>.</li>
 <li>Sugiura-Ogasawara, M., et al. (2021). "Management of recurrent pregnancy loss: A guideline from the Japanese Society for Reproductive Medicine." <em>Reproductive Medicine and Biology</em>.</li>
 <li>Branch, D. W., et al. (2018). "Antiphospholipid Syndrome and Pregnancy Loss." <em>Obstetrics & Gynecology</em>.</li>
 <li>Kwak-Kim, J., et al. (2019). "Reproductive Immunology: From Basic Science to Clinical Practice." <em>Frontiers in Immunology</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el) {
 el.style.display = (el.style.display === 'block') ? 'none' : 'block';
 }
}
</script>
</body>
</html>